PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: Regulation of proliferation and differentiation by multiple intracellular signaling pathways

Molecular and Cellular Neurosciences

Volumn 15, Issue 3, 2000, Pages 314-329

  Baron, Wia ^a   Metz, Bernard ^a   Bansal, Rashmi ^b   Hoekstra, Dick ^a   De Vries, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MOLECULAR DYNAMICS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALIA;

EID: 0034029228     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1999.0827     Document Type: Article

References (53)

1. Arcaro A., Wymann M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296:1993;297-301.
2. Asotra K., Macklin W. B. Developmental expression of protein kinase C isozymes in oligodendrocytes and their differential modulation by 4β-phorbol-12,13-dibutyrate. J. Neurosci. Res. 39:1994;273-289.
3. Avossa D., Pfeiffer S. E. Transient reversion of O4+ GalC-ligodendrocyte progenitor development in response to the phorbol ester TPA. J. Neurosci. Res. 34:1993;113-128.
4. Bansal R., Pfeiffer S. E. Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev. Biol. 162:1994;511-524.
5. Bansal R., Pfeiffer S. E. Regulation of FGF receptors in the oligodendrocyte lineage. Mol. Cell. Neurosci. 7:1996;263-275.
6. Baron W., De Jonge J. C., de Vries H., Hoekstra D. Regulation of oligodendrocyte differentiation: Protein kinase C activation prevents differentiation of O2A progenitor cells towards oligodendrocytes. Glia. 22:1998;121-129.
7. Baron W., de Vries E. J., de Vries H., Hoekstra D. Protein kinase C prevents oligodendrocyte differentiation: Modulation of actin cytoskeleton and cognate polarized membrane traffic. J. Neurobiol. 41:1999;385-398.
8. Barres B. A., Raff M. C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron. 12:1994;935-942.
9. Bhat N. R. Phosphorylation of MARCKS (80-kDa) protein, a major substrate for protein kinase C in oligodendroglial progenitors. J. Neurosci. Res. 30:1991;340-349.
10. Bhat N. R., Zhang P. Activation of mitogen-activated protein kinases in oligodendrocytes. J. Neurochem. 66:1996;1986-1994.
11. Bögler O., Wren D., Barnett S. C., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. USA. 87:1990;6368-6372.
12. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J. Biol. Chem. 268:1994;32023-32026.
13. Claesson-Welsh L. Mechanisms of action of platelet-derived growth factor. Int. J. Biochem. Cell Biol. 28:1996;373-385.
14. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
15. Deloulme J. C., Janet T., Pettmann B., Laeng P., Knoetgen M.-F., Sensenbrenner M., Baudier J. Phosphorylation of the MARCKS protein (P87), a major protein kinase C substrate, is not an obligatory step in the mitogenic signaling pathway of basic fibroblast growth factor in rat oligodendrocytes. J. Neurochem. 58:1992;567-578.
16. Dudley D. T., Pang L., Decker S. J., Bridges A. J., Saltiel A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
17. Ellison J. A., de Vellis J. Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage. J. Neurosci. Res. 37:1994;116-128.
18. Eriksson A., Nånberg E., Rönnstrand L., Engström U., Hellman U., Rupp E., Carpenter G., Heldin C.-H., Claesson-Welsh L. Demonstration of functionally different interactions between phospholipase C-γ and the two types of platelet-derived growth factor receptors. J. Biol. Chem. 270:1995;7773-7781.
19. Frodin M., Peraldi P., Van Obberghen E. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cell. J. Biol. Chem. 269:1994;6207-6214.
20. - oligodendrocyte progenitors. Dev. Biol. 159:1993;618-630.
21. Graves L. M., Bornfeldt K. E., Raines E. W., Potts B. C., Macdonald S. G., Ross R., Krebs E. G. Protein kinase A antagonizes platelet-derived growth factor signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA. 90:1993;10300-10304.
22. Guay J., Lambert H., Gingras-Breton G., Lavoie J. N., Huot J., Landry J. Regulation of actin filament dynamics by p38 MAP kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110:1997;357-368.
23. Hart I. K., Richardson W. D., Heldin C.-H., Westermark B., Raff M. C. PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development. 105:1989a;595-603.
24. Hart I. K., Richardson W. D., Bolsover S. R., Raff M. C. PDGF and intracellular signaling in the timing of oligodendrocyte differentiation. J. Cell Biol. 109:1989b;3411-3417.
25. Hidaka H., Sasaki Y., Tanaka T., Ohno S., Fujii Y., Nagata T. N-(6-aminohexyl)-5-chloro-1-naphtalensulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc. Natl. Acad. Sci. USA. 78:1981;4354-4357.
26. Kanda S., Hodgkin M. N., Woodfield R. J., Wakelam M. J. O., Thomas G., Claesson-Welsh L. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J. Biol. Chem. 272:1997;23347-23353.
27. Kapeller R., Cantley L. C. Phosphatidylinositol 3-kinase. BioEssays. 16:1994;565-575.
28. Kim H. A., DeClue J. E., Ratner N. cAMP-dependent protein kinase A is required for Schwann cell growth: Interactions between the cAMP and neuregulin/tyrosine kinase pathways. J. Neurosci. Res. 49:1997;236-247.
29. Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front. Biosci. 15:1999;165-177.
30. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
31. McCarthy K. D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:1980;890-902.
32. McKinnon R. D., Matsui T., Dubois-Dalcq M., Aaronson S. A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 5:1990;603-614.
33. Meisenhelder J., Suh P.-G., Rhee S. G., Hunter T. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell. 57:1989;1109-1122.
34. Mohammadi M., Honegger A. M., Rotin D., Fisher R., Bellot F., Li W., Dionne C. A., Jaye M., Rubinstein M., Schlessinger J. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol. 11:1991;5068-5078.
35. Mohammadi M., Dionne C. A., Li W., Li M., Spivak T., Honegger A. M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:1992;682-684.
36. Mohammadi M., Dikic I., Sorokin A., Burgess W. H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:1996;977-989.
37. Noble M., Murray K., Stroobant P., Waterfield M. D., Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 333:1988;560-562.
38. Pende M., Fisher T. L., Simpson P. B., Russell J. T., Blenis J., Gallo V. Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: Role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway. J. Neurosci. 17:1997;1291-1301.
39. Peters K., Marie J., Wilson E., Ives H., Escobedo J., Del Rosario M., Mirda D., Williams L. T. Point mutation of an FGF receptor abolishes phosphatidyl turnover and Ca2+ but not mitogenesis. Nature. 358:1992;678-681.
40. Peterson G. L. A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 83:1977;346-350.
41. Pfeiffer S. E., Warrington A. E., Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3:1993;191-197.
42. Price D. J., Grove J. R., Calvo V., Avruch J., Bierer B. E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 257:1992;973-977.
43. Radhakrishna M., Almazan G. Protein kinases mediate basic fibroblast growth factor's stimulation of proliferation and c-fos induction in oligodendrocyte progenitors. Mol. Brain Res. 24:1994;118-128.
44. Raff M. C., Lillien L. E., Richardson W. D., Burne J. F., Noble M. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 333:1988;562-565.
45. Raible D. W., McMorris F. A. Oligodendrocyte differentiation and progenitor proliferation are independently regulated by cyclic AMP. J. Neurosci. Res. 34:1993;287-294.
46. Sevetson B. R., Kong X., Lawrence C. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;10305-10309.
47. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
48. Vemuri G. S., McMorris F. A. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for their survival. Development. 122:1996;2529-2537.
49. Wayman G. A., Tokumitsu H., Soderling T. R. Inhibitory cross-talk by cAMP kinase on the calmodulin-dependent protein kinase cascade. J. Biol. Chem. 272:1997;16073-16076.
50. Wymann M. P., Arcaro A. Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangement in fibroblasts. Biochem. J. 298:1994;517-520.
51. Yong V. W., Cheung J. C. B., Uhm J. H., Kim S. U. Age-dependent decrease of process formation by cultured oligodendrocytes is augmented by protein kinase C stimulation. J. Neurosci. Res. 29:1991;87-99.
52. Yu J.-C., Heidaran M. A., Pierce J. A., Gutkind J. S., Lombardi D., Ruggiero M., Aaronson S. A. Tyrosine mutations within the α platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol. Cell. Biol. 11:1991;3780-3785.
53. Yule D. I., Williams J. A. U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J. Biol. Chem. 267:1992;13830-13835.